Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$0.42 USD
+0.02 (5.00%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $0.42 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Bionano Genomics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -232.49 | -132.60 | -72.44 | -41.11 | -29.82 |
Depreciation/Amortization & Depletion | 90.65 | 10.48 | 3.70 | 1.48 | 1.13 |
Net Change from Assets/Liabilities | -14.77 | -28.59 | -7.65 | -3.44 | -4.97 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 31.43 | 25.89 | 4.46 | 4.75 | 4.13 |
Net Cash From Operating Activities | -125.18 | -124.82 | -71.93 | -38.31 | -29.53 |
Property & Equipment | -1.69 | -2.38 | -0.82 | 0.00 | -0.06 |
Acquisition/ Disposition of Subsidiaries | 0.10 | -30.65 | -49.09 | -2.45 | 0.00 |
Investments | 25.75 | 116.69 | -226.91 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | -0.89 | -1.25 | 0.00 | 0.00 |
Net Cash from Investing Activities | 24.16 | 82.77 | -278.06 | -2.45 | -0.06 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 57.83 | 23.62 | 352.82 | 68.63 | 20.56 |
Issuance (Repayment) of Debt | 70.95 | -0.04 | -15.01 | -3.23 | 8.32 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -1.50 | 1.50 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -14.97 | -0.58 | -1.70 | -2.00 | 0.00 |
Net Cash from Financing Activities | 113.82 | 23.01 | 336.11 | 61.90 | 30.38 |
Effect of Exchange Rate Changes | 0.07 | -0.04 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 12.86 | -19.08 | -13.88 | 21.14 | 0.79 |
Cash at Beginning of Period | 5.49 | 24.57 | 38.45 | 17.31 | 16.52 |
Cash at End of Period | 18.35 | 5.49 | 24.57 | 38.45 | 17.31 |
Diluted Net EPS | -6.81 | -4.60 | -2.60 | -3.90 | -19.90 |
Fiscal Year End for Bionano Genomics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -47.65 | -31.42 | -232.49 | -188.60 | -76.04 |
Depreciation/Amortization & Depletion | 5.19 | 2.81 | 90.65 | 87.24 | 6.36 |
Net Change from Assets/Liabilities | 0.94 | 5.30 | -14.77 | -8.52 | -9.60 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -7.59 | -4.82 | 31.43 | 14.48 | 10.16 |
Net Cash From Operating Activities | -49.11 | -28.13 | -125.18 | -95.40 | -69.11 |
Property & Equipment | -0.10 | -0.03 | -1.69 | -0.95 | -0.84 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.10 | 0.10 | 0.10 |
Investments | 76.32 | 47.61 | 25.75 | 80.38 | 46.88 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
Net Cash from Investing Activities | 76.22 | 47.59 | 24.16 | 79.53 | 46.10 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 27.61 | 15.45 | 57.83 | 46.53 | 33.60 |
Issuance (Repayment) of Debt | -43.03 | -36.68 | 70.95 | -0.03 | -0.02 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -8.18 | -0.39 | -14.97 | -1.16 | -0.84 |
Net Cash from Financing Activities | -23.60 | -21.62 | 113.82 | 45.33 | 32.74 |
Effect of Exchange Rate Changes | -0.03 | -0.03 | 0.07 | 0.02 | 0.03 |
Net Change In Cash & Equivalents | 3.49 | -2.19 | 12.86 | 29.48 | 9.77 |
Cash at Beginning of Period | 18.35 | 18.35 | 5.49 | 5.49 | 5.49 |
Cash at End of Period | 21.83 | 16.16 | 18.35 | 34.97 | 15.26 |
Diluted Net EPS | -0.24 | -0.60 | -1.15 | -3.22 | -1.24 |